Effects of alpha 1-acid glycoprotein in different rodent models of shock

It was the aim of the present study to investigate the effects of the acute phase protein alpha 1-acid glycoprotein in different models of shock. The human plasma preparation used was without effect on mortality in lipopolysaccharide-injected mice when administered in two different doses (1 or 0.33...

Full description

Saved in:
Bibliographic Details
Published in:Fundamental & clinical pharmacology 1998, Vol.12 (2), p.173-181
Main Authors: Muchitsch, E M, Auer, W, Pichler, L
Format: Article
Language:English
Subjects:
Animals
Disease Models, Animal
Female
Hemodynamics - drug effects
Humans
Lipopolysaccharides
Male
Mice
Mice, Inbred C57BL
Orosomucoid - pharmacology
Orosomucoid - therapeutic use
Peritonitis - drug therapy
Peritonitis - microbiology
Rats
Rats, Sprague-Dawley
Salmonella typhimurium - metabolism
Sepsis - drug therapy
Sepsis - microbiology
Shock, Hemorrhagic - drug therapy
Species Specificity
Survival Analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:It was the aim of the present study to investigate the effects of the acute phase protein alpha 1-acid glycoprotein in different models of shock. The human plasma preparation used was without effect on mortality in lipopolysaccharide-injected mice when administered in two different doses (1 or 0.33 g/kg i.v.) and according to different treatment schedules. The same preparation significantly increased survival rate (48 h) in rats with septic peritonitis. This effect was seen when alpha 1-acid glycoprotein (200 mg/kg i.v.) was given 15 min prior to and 24 h after cecal puncture. All other dose regimes tested were without significant effect on survival rate. A hemorrhagic/hypovolemic shock model (including a defined trauma) in rats resuscitated with 200 mg/kg alpha 1-acid glycoprotein resulted in significantly higher values of mean arterial blood pressure, cardiac output and stroke volume when compared to corresponding values obtained after resuscitation with Ringer's solution or 200 mg/kg albumin i.v. (free of alpha 1-acid glycoprotein; placebo formulation). Taking all other possible mechanisms of alpha 1-acid glycoprotein into consideration, the partially protective effects of the preparation are explained by enhancing the capillary barrier function and thereby maintaining perfusion of vital organs.
ISSN:0767-3981
1472-8206
DOI:10.1111/j.1472-8206.1998.tb00938.x